Top member reports
No meetings
Consensus community valuation
The consensus valuation is for members only and has been removed from this chart. Click for membership options.
Created with Highcharts 5.0.2Mar 2024Mar 2024Mar 2024Mar 2024Mar 2024Mar 2024Apr 2024Apr 2024Apr 2024Apr 2024Apr 20240.0050.00750.010.01250.0150.0175
Contributing Members
Content is delayed by one month. Upgrade your membership to unlock all content. Click for membership options.
#New Patent~Japan 9/2/21
stale
Added 4 years ago

Regeneus Ltd (ASX: RGS) (Regeneus or the Company), a clinical-stage regenerative medicine company, announced today that the Japanese Patent Office has decided to grant the Company a new key patent, covering the use of its lead stem cell technology Progenza™ to treat pain, through to 2032.

DISC: I don't hold but do hold OCC

View Attachment

Read More